医学信息Issue(18)：57-57,58,2.
周剂量奈达铂同步放化疗治疗中晚期宫颈癌的临床研究
Clinical study on weekly nadaplatin concurrent chemoradiotherapy for local advanced cervical cancer
陈静 1陆谔梅 1黄建1
作者信息
- 1. 南京医科大学附属江苏省肿瘤医院妇放科，江苏 南京 210009
- 折叠
摘要
Abstract
Objective To analyze the clinical ef ect and toxicity of nadaplatin concurrent chemoradiotherapy for local y advanced cervical cancer. Methods Fifty patients with local advanced cervical cancer were randomly divided into nadaplatin concurrent chemo-radiotherapy group ( 25 cases) and only radiotherapy group ( 25 cases) . The survival rates toxicity of the two groups were compared. Results The total ef ective rates were 92.0% and 80.0%, 2-year survival rates were 76.0% and 56.0%, recurrence and metastasis rates were 16.0% and 44.0% in nadaplatin concurrent chemo-radiotherapy group and only radiotherapy group respectively with significant dif erence(P<0.05).But the incidence of bone marrow inhibition and gastrointestinal reaction in nadaplatin concurrent chemo-radiotherapy group were higher than that in only radiotherapy group. Conclusion Compared with only radiotherapy group,the total ef ective rates and survival rates were higher in nadaplatin concurrent chemo-radiotherapy group,but bone marrow inhibition and gastrointestinal reaction were severer for local advanced cervical cancer.关键词
同步放化疗/宫颈癌/疗效/毒副作用Key words
Concurrent Chemoradiotherapy/Cervical Cancer/Clinical Ef ect/Toxicity引用本文复制引用
陈静,陆谔梅,黄建..周剂量奈达铂同步放化疗治疗中晚期宫颈癌的临床研究[J].医学信息,2013,(18):57-57,58,2.
